Recommended Monophasic Oral Contraceptive Regimen
For patients requiring a monophasic oral contraceptive, a formulation containing 30-35 μg of ethinyl estradiol with a progestin such as levonorgestrel or norgestimate is recommended as the first-line option. 1
Rationale for Monophasic COC Selection
Monophasic oral contraceptives provide several advantages:
- Each tablet contains the same dose of estrogen and progestin throughout the active pill cycle
- Simpler regimen compared to multiphasic options
- Excellent contraceptive efficacy (typical use failure rate 5-9%) 2
- Predictable bleeding patterns for most users
Specific Recommended Formulations
- First-line option: 30-35 μg ethinyl estradiol with levonorgestrel or norgestimate 1
- Alternative option: 30 μg ethinyl estradiol with desogestrel (demonstrated excellent efficacy and cycle control in clinical trials) 3
- Lower-dose option: 20 μg ethinyl estradiol with 100 μg levonorgestrel (Pearl index 0.88, good tolerability profile) 4
Administration Protocol
Standard 28-Day Regimen
- 21-24 active hormone pills followed by 4-7 placebo pills
- Can be initiated using either Sunday start or Day 1 start 5
- For Sunday start: First pill taken on first Sunday after menstruation begins
- For Day 1 start: First pill taken on first day of menstruation
Missed Pill Instructions
If one hormonal pill is late (<24 hours):
- Take the late pill as soon as possible
- Continue taking remaining pills at usual time
- No additional contraceptive protection needed 1
If one hormonal pill is missed (24 to <48 hours):
- Take the missed pill as soon as possible
- Continue taking remaining pills at usual time
- Use backup contraception for 7 consecutive days 1
If two or more consecutive hormonal pills are missed (≥48 hours):
- Take the most recent missed pill immediately (discard other missed pills)
- Continue taking remaining pills at usual time
- Use backup contraception for 7 consecutive days
- Consider emergency contraception if pills were missed during first week and unprotected intercourse occurred in previous 5 days 1
Benefits Beyond Contraception
Monophasic COCs provide several non-contraceptive benefits:
- Decreased menstrual cramping and blood loss
- Improvement in acne
- Protection against endometrial and ovarian cancers with >3 years of use
- Management of conditions exacerbated cyclically (e.g., migraine without aura, epilepsy, irritable bowel syndrome) 1
Safety Considerations
- Baseline risk of venous thromboembolism in young women: up to 1 per 10,000 woman-years
- COCs increase risk to 3-4 per 10,000 woman-years
- For comparison, pregnancy/postpartum period: 10-20 per 10,000 woman-years 1
- COCs are contraindicated in women with history of VTE, stroke, cardiovascular disease, age ≥35 years who smoke ≥15 cigarettes daily 6
Common Pitfalls and Caveats
Medication interactions: Certain medications (e.g., anticonvulsants, rifampin) may decrease COC effectiveness 6
Missed pills: Frequent missed pills significantly reduce effectiveness; consider alternative methods less dependent on user adherence (IUD, implant) for patients with adherence challenges 1
Breakthrough bleeding: Common during initial use and typically decreases with continued use; counsel patients that this does not indicate reduced effectiveness 6
Extended or continuous regimens: May be appropriate for patients with medical conditions like anemia, severe dysmenorrhea, or endometriosis, but may have more unscheduled bleeding, especially in early months 1, 6
STI protection: COCs do not protect against sexually transmitted infections; condoms should be recommended if STI protection is needed 6
Monophasic oral contraceptives remain one of the best-studied medications ever prescribed, are completely reversible, and have no negative effect on long-term fertility 1.